DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Moore MJ et al.
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada Clinical Trials Group.
Journal of Clinical Oncology 2007;
25 (15) 1960-1966
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.